Previous close | 1.2500 |
Open | 1.5100 |
Bid | 1.2300 |
Ask | 1.4100 |
Strike | 210.00 |
Expiry date | 2023-06-16 |
Day's range | 1.2700 - 1.5100 |
Contract range | N/A |
Volume | |
Open interest | 1.64k |
Denali Therapeutics Inc. (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Recently, Moderna (NASDAQ: MRNA)'s CEO highlighted a big risk for the company: Demand for its COVID-19 vaccine is going to crater. It's a big enough decline to get investors worried. Moderna is anticipating a big drop in demand this year as concerns around COVID-19 subside.
What makes a top growth stock? It's generated billions of dollars thanks to its coronavirus vaccine -- but the company has other major growth drivers on the way. Let's find out more about this ultimate growth stock to buy now.